P-glycoprotein expression induced by glucose depletion enhanced the chemo sensitivity in human hepatocellular carcinoma cell-lines

被引:14
作者
Cheng, SCS [1 ]
Zhou, J [1 ]
Xie, Y [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China
关键词
chemoresistance; glucose depletion; hepatocellular carcinoma; P-glycoprotein; verapamil;
D O I
10.1016/j.cellbi.2004.12.010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Chemoresistance in cancer cells is frequently associated with an over-expression of the P-glycoprotein (P-gp). The expression of P-gp can be regulated as the cells encounter a number of chemical, physical or environmental stimuli. In this study, P-gp was found gradually expressed in a human hepatocellular carcinoma (HCC) QGY-7703 cells after 48 It of culturing in glucose-free medium. This phenomenon disappeared after the removal of glucose deprivation culture conditions. Mdrl-cDNA isolated from the cell line cultured in glucose-free conditions (namely QGY-7703G), was transiently transformed into the parent QGY-7703 cells, and multidrug resistance was eventually induced. Results from XTT cytotoxicity assays indicated that the mdrl gene was functional and the P-gp could restore the QGY-7703 cell's ability to withstand high concentrations of a number of chemotherapeutic agents. A P-gp inhibitor, verapamil, could completely reverse the cellular drug resistance when applied to the QGY-7703G cells. Our results indicated that an alteration of a specific state in cells caused by an external stimulus in vitro may lead to an expression of stress proteins (e.g. P-gp), which may enhance the cells' survival in adverse conditions. The expressed P-gp induced by glucose deprivation has a functional role in affecting the chemosensitivity in HCC QGY-7703G cells. Inhibition of P-gp activity may enhance the effect of the cancer cells towards cancer chemotherapy. (c) 2005 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 28 条
[1]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[2]   A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[3]   ABC transporters in lipid transport [J].
Borst, P ;
Zelcer, N ;
van Helvoort, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1486 (01) :128-144
[4]   Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance [J].
Fu, LW ;
Liang, YJ ;
Deng, LW ;
Ding, Y ;
Chen, LM ;
Ye, YL ;
Yang, XP ;
Pan, QC .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (04) :349-356
[5]   Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics [J].
Gonçalves, A ;
Braguer, D ;
Kamath, K ;
Martello, L ;
Briand, C ;
Horwitz, S ;
Wilson, L ;
Jordan, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11737-11742
[6]   Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells [J].
Granzotto, M ;
Drigo, H ;
Candussio, L ;
Rosati, A ;
Bartoli, F ;
Giraldi, T ;
Decorti, G .
CANCER LETTERS, 2004, 205 (01) :107-115
[7]   Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance [J].
Hrycyna, CA .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2001, 12 (03) :247-256
[8]   A role for P-glycoprotein in regulating cell death [J].
Johnstone, RW ;
Ruefli, AA ;
Tainton, KM ;
Smyth, MJ .
LEUKEMIA & LYMPHOMA, 2000, 38 (1-2) :1-+
[9]   Effect of PSC 833, an inhibitor of P-glycoprotein on N-methyl-N-nitrosourea induced mammary carcinogenesis in rats [J].
Kankesan, J ;
Vanama, R ;
Yusuf, A ;
Thiessen, JJ ;
Ling, V ;
Rao, PM ;
Rajalakshmi, S ;
Sarma, DSR .
CARCINOGENESIS, 2004, 25 (03) :425-430
[10]  
Komdeur R, 2004, ANTICANCER RES, V24, P291